China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC - Get Free Report) fell 10.1% during mid-day trading on Monday . The company traded as low as $1.69 and last traded at $1.69. 48,972 shares were traded during mid-day trading, a decline of 96% from the average session volume of 1,191,733 shares. The stock had previously closed at $1.88.
China SXT Pharmaceuticals Stock Up 2.3%
The stock has a 50 day simple moving average of $1.74 and a 200 day simple moving average of $2.66.
China SXT Pharmaceuticals Company Profile
(
Get Free Report)
China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.
Featured Stories
Before you consider China SXT Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and China SXT Pharmaceuticals wasn't on the list.
While China SXT Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.